Ahmedabad-based CoSara Diagnostics has become the first and only Indian company so far to receive a licence from the Central Drugs Standard Control Organisation (CDSCO) to manufacture coronavirus (Covid-19) diagnostic test kits.
The company now plans to send sample batches to National Institute of Virology (NIV), Pune, for validation, following which it would apply for a manufacturing licence with the Gujarat government.
A joint venture of Synbiotics, a wholly owned subsidiary of Ambalal Sarabhai Enterprises (ASE), and CoDiagnostics, CoSara Diagnostics is a Gujarat-based molecular diagnostic company.
While it did not share the exact pricing of the kits, the company’s chief

)